Jacobs Levy Equity Management Inc. Sells 4,146 Shares of Inari Medical, Inc. (NASDAQ:NARI)

Jacobs Levy Equity Management Inc. lessened its stake in shares of Inari Medical, Inc. (NASDAQ:NARI) by 3.4% during the 4th quarter, Holdings Channel reports. The fund owned 118,576 shares of the company’s stock after selling 4,146 shares during the period. Jacobs Levy Equity Management Inc.’s holdings in Inari Medical were worth $6,053,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of NARI. Barclays PLC boosted its position in Inari Medical by 9.7% during the 3rd quarter. Barclays PLC now owns 288,079 shares of the company’s stock valued at $11,881,000 after acquiring an additional 25,365 shares in the last quarter. AMI Asset Management Corp acquired a new stake in shares of Inari Medical in the 4th quarter worth $1,651,000. KBC Group NV boosted its position in shares of Inari Medical by 31.5% in the 4th quarter. KBC Group NV now owns 2,333 shares of the company’s stock worth $119,000 after purchasing an additional 559 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Inari Medical in the 4th quarter worth $45,000. Finally, Jennison Associates LLC boosted its position in shares of Inari Medical by 11.8% in the 4th quarter. Jennison Associates LLC now owns 1,763,258 shares of the company’s stock worth $90,014,000 after purchasing an additional 186,617 shares in the last quarter. Institutional investors own 90.98% of the company’s stock.

Inari Medical Price Performance

Inari Medical stock opened at $79.97 on Wednesday. The stock has a market capitalization of $4.68 billion, a price-to-earnings ratio of -59.24 and a beta of 1.02. Inari Medical, Inc. has a 1-year low of $39.76 and a 1-year high of $79.99. The business has a fifty day moving average price of $79.97 and a 200-day moving average price of $70.01.

Inari Medical Company Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.